153 related articles for article (PubMed ID: 22153791)
1. Increased diagnosis of thin superficial spreading melanomas: A 20-year study.
Frangos JE; Duncan LM; Piris A; Nazarian RM; Mihm MC; Hoang MP; Gleason B; Flotte TJ; Byers HR; Barnhill RL; Kimball AB
J Am Acad Dermatol; 2012 Sep; 67(3):387-94. PubMed ID: 22153791
[TBL] [Abstract][Full Text] [Related]
2. Dysplastic nevi in relation to superficial spreading melanoma.
Titus-Ernstoff L; Barnhill RL; Duray PH; Ernstoff MS; Kirkwood JM
Cancer Epidemiol Biomarkers Prev; 1993; 2(2):99-101. PubMed ID: 8467253
[TBL] [Abstract][Full Text] [Related]
3. Histologic processing and reporting of cutaneous pigmented lesions: recommendations based on a survey of 94 dermatopathologists.
Kolman O; Hoang MP; Piris A; Mihm MC; Duncan LM
J Am Acad Dermatol; 2010 Oct; 63(4):661-7. PubMed ID: 20846568
[TBL] [Abstract][Full Text] [Related]
4. Reliability of the histopathologic diagnosis of melanocytic dysplasia. The Dysplastic Nevus Panel.
Weinstock MA; Barnhill RL; Rhodes AR; Brodsky GL
Arch Dermatol; 1997 Aug; 133(8):953-8. PubMed ID: 9267239
[TBL] [Abstract][Full Text] [Related]
5. Frequency of dysplastic nevi among nevomelanocytic lesions submitted for histopathologic examination. Time trends over a 37-year period.
Barnhill RL; Kiryu H; Sober AJ; Mihm MC
Arch Dermatol; 1990 Apr; 126(4):463-5. PubMed ID: 2321991
[TBL] [Abstract][Full Text] [Related]
6. The impact of total body photography on biopsy rate in patients from a pigmented lesion clinic.
Risser J; Pressley Z; Veledar E; Washington C; Chen SC
J Am Acad Dermatol; 2007 Sep; 57(3):428-34. PubMed ID: 17624623
[TBL] [Abstract][Full Text] [Related]
7. Melanoma risk in individuals with clinically atypical nevi.
Kang S; Barnhill RL; Mihm MC; Fitzpatrick TB; Sober AJ
Arch Dermatol; 1994 Aug; 130(8):999-1001. PubMed ID: 8053717
[TBL] [Abstract][Full Text] [Related]
8. The role of reflectance confocal microscopy in differentiating melanoma in situ from dysplastic nevi with severe atypia: A cross-sectional study.
Fraga-Braghiroli N; Grant-Kels JM; Oliviero M; Rabinovitz H; Ferenczi K; Scope A
J Am Acad Dermatol; 2020 Oct; 83(4):1035-1043. PubMed ID: 32442695
[TBL] [Abstract][Full Text] [Related]
9. Ocular melanoma: epidemiology, clinical presentation and relationship with dysplastic nevi.
Richtig E; Langmann G; Müllner K; Smolle J
Ophthalmologica; 2004; 218(2):111-4. PubMed ID: 15004500
[TBL] [Abstract][Full Text] [Related]
10. Atypical (dysplastic) nevi: outcomes of surgical excision and association with melanoma.
Reddy KK; Farber MJ; Bhawan J; Geronemus RG; Rogers GS
JAMA Dermatol; 2013 Aug; 149(8):928-34. PubMed ID: 23760581
[TBL] [Abstract][Full Text] [Related]
11. Atypical cellular blue nevi (cellular blue nevi with atypical features): lack of consensus for diagnosis and distinction from cellular blue nevi and malignant melanoma ("malignant blue nevus").
Barnhill RL; Argenyi Z; Berwick M; Duray PH; Erickson L; Guitart J; Horenstein MG; Lowe L; Messina J; Paine S; Piepkorn MW; Prieto V; Rabkin MS; Schmidt B; Selim A; Shea CR; Trotter MJ
Am J Surg Pathol; 2008 Jan; 32(1):36-44. PubMed ID: 18162768
[TBL] [Abstract][Full Text] [Related]
12. A subgroup of melanocytic nevi on the distal lower extremity (ankle) shares features of acral nevi, dysplastic nevi, and melanoma in situ: a potential misdiagnosis of melanoma in situ.
Khalifeh I; Taraif S; Reed JA; Lazar AF; Diwan AH; Prieto VG
Am J Surg Pathol; 2007 Jul; 31(7):1130-6. PubMed ID: 17592281
[TBL] [Abstract][Full Text] [Related]
13. [Focal melanocytic atypia in dysplastic nevus cell nevi. Results of a serial section study].
Sigg C; Pelloni F; Schnyder UW
Hautarzt; 1989 Nov; 40(11):701-7. PubMed ID: 2606669
[TBL] [Abstract][Full Text] [Related]
14. Dysplastic nevus--risk factor or disguise for melanoma.
Dediol I; Bulat V; Zivković MV; Marković BM; Situm M
Coll Antropol; 2011 Sep; 35 Suppl 2():311-3. PubMed ID: 22220461
[TBL] [Abstract][Full Text] [Related]
15. Histopathologic recognition and grading of dysplastic melanocytic nevi: an interobserver agreement study.
Duncan LM; Berwick M; Bruijn JA; Byers HR; Mihm MC; Barnhill RL
J Invest Dermatol; 1993 Mar; 100(3):318S-321S. PubMed ID: 8440913
[TBL] [Abstract][Full Text] [Related]
16. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
Boyd AS; Shakhtour B; Shyr Y
J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
[TBL] [Abstract][Full Text] [Related]
17. [Nevus and malignant cutaneous melanoma].
Morales Suárez-Varela MM; Llopis González A; Lacasaña Navarro M; Ferrándiz Ferragud J
Rev Sanid Hig Publica (Madr); 1991; 65(3):233-8. PubMed ID: 1801183
[TBL] [Abstract][Full Text] [Related]
18. Agreement of dermatopathologists in the evaluation of clinically difficult melanocytic lesions: how golden is the 'gold standard'?
Braun RP; Gutkowicz-Krusin D; Rabinovitz H; Cognetta A; Hofmann-Wellenhof R; Ahlgrimm-Siess V; Polsky D; Oliviero M; Kolm I; Googe P; King R; Prieto VG; French L; Marghoob A; Mihm M
Dermatology; 2012; 224(1):51-8. PubMed ID: 22433231
[TBL] [Abstract][Full Text] [Related]
19. Dysplastic naevus vs. in situ melanoma: digital dermoscopy analysis.
Burroni M; Sbano P; Cevenini G; Risulo M; Dell'eva G; Barbini P; Miracco C; Fimiani M; Andreassi L; Rubegni P
Br J Dermatol; 2005 Apr; 152(4):679-84. PubMed ID: 15840098
[TBL] [Abstract][Full Text] [Related]
20. Dysplastic nevus in histologic contiguity with acquired nonfamilial melanoma. Clinicopathologic experience in a 100-bed hospital.
Duray PH; Ernstoff MS
Arch Dermatol; 1987 Jan; 123(1):80-4. PubMed ID: 3800426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]